Single-Use Bioreactors Get Nod: Recent Survey Finds Commercial-Stage Use of Disposables Continuing on Upward Trajectory

摘要

Bioreactors are constantly evolving, with improvements being introduced rapidly. To assess how the industry will be adopting and using some of these new technologies, at both clinical and commercial manufacturing scales, we asked more than 300 biomanufac-turers their approaches to adoption of these new technologies. The results, contained in BioPlan Associates' 9th Annual Report and Survey of Bio-pharmaceutical Manufacturers, suggest that biologies currently in the pipeline will likely be made in single-use, disposable bioreactors. Respondents indicated a clear preference for these devices, and it is likely they will be overtaking fixed, stainless facilities in the near term.